Status:
UNKNOWN
Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients
Lead Sponsor:
Jessa Hospital
Collaborating Sponsors:
Hasselt University
University Hospital, Antwerp
Conditions:
COVID-19
Eligibility:
All Genders
Phase:
NA
Brief Summary
Rationale In a very short time corona virus disease 2019 (COVID-19) has become a pandemic with high morbidity and mortality. The main cause of death is respiratory failure including acute respiratory ...
Eligibility Criteria
Inclusion
- All patients with COVID-19 that die during hospitalization in Jessa hospital. COVID-19 is defined as either a positive SARS CoV-2 PCR result OR a high clinical suspicion combined with typical radiologic findings in the absence of an alternative explanation for the clinical picture.
Exclusion
- None
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04366882
Start Date
April 14 2020
End Date
December 1 2023
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Belgium